IpsA, a novel LacI-type regulator, is required for inositol-derived lipid formation in Corynebacteria and Mycobacteria

BACKGROUND: The development of new drugs against tuberculosis and diphtheria is focused on disrupting the biogenesis of the cell wall, the unique architecture of which confers resistance against current therapies. The enzymatic pathways involved in the synthesis of the cell wall by these pathogens a...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumgart, Meike, Luder, Kerstin, Grover, Shipra, Gätgens, Cornelia, Besra, Gurdyal S, Frunzke, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899939/
https://www.ncbi.nlm.nih.gov/pubmed/24377418
http://dx.doi.org/10.1186/1741-7007-11-122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899939/
https://www.ncbi.nlm.nih.gov/pubmed/24377418
http://dx.doi.org/10.1186/1741-7007-11-122

Ejemplares similares